Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Incidence and Prognosis of Primary Malignancies in Ataxia-Telangiectasia Patients: A Report from the Ataxia-Telangiectasia Clinical Center (ATCC)

Richa Sharma, Aimee Magnarelli, Qi Liu, Fan Wang, Yutaka Yasui, Matthew J. Ehrhardt, Howard Lederman

Blood (2023) 142 (Supplement 1): 6091.

https://doi.org/10.1182/blood-2023-191249

Published: 2023

Journal Articles

Improved Neurocognitive Outcomes with Contemporary Treatments in Survivors of Early Adolescent and Young Adult Hematologic Malignancies from the Childhood Cancer Survivor Study

Amy Yuan Wang, Annalynn M Williams, Yan Chen, Yutaka Yasui, Wendy Stock, Wendy Leisenring, Gregory Armstrong, Kevin Oeffinger, Eric J. Chow, Kevin R. Krull, Tara O. Henderson

Blood (2023) 142 (Supplement 1): 3776.

https://doi.org/10.1182/blood-2023-182329

Published: 2023

Journal Articles

New Onset Neurocognitive Impairment in Long-Term Survivors of Early Adolescent and Young Adult Hematologic Malignancies: A Report from the Childhood Cancer Survivor Study

Amy Yuan Wang, Annalynn M Williams, Yan Chen, Yutaka Yasui, Wendy Stock, Wendy Leisenring, Gregory Armstrong, Kevin Oeffinger, Eric J. Chow, Kevin R. Krull, Tara O. Henderson

Blood (2023) 142 (Supplement 1): 670.

https://doi.org/10.1182/blood-2023-182160

Published: 2023

Journal Articles

Development of a Genetic Risk Score for Albuminuria in Pediatric Patients with Sickle Cell Anemia

Rima Zahr, Guolian Kang, Sara Rashkin, Yutaka Yasui, Csaba Kovesdy, Clifford M Takemoto, Jeffrey D. Lebensburger, Mitchell Weiss, Santosh L. Saraf, Kenneth I. Ataga

Blood (2023) 142 (Supplement 1): 1141.

https://doi.org/10.1182/blood-2023-185213

Published: 2023

Journal Articles

A Comparison of Financial Hardship Among Survivors of Childhood Cancer Treated with and without Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study

David K. Buchbinder, Neel S. Bhatt, Huiqi Wang, Yutaka Yasui, Saro H. Armenian, Smita Bhatia, Eric J. Chow, I-Chan Huang, Anne C. Kirchhoff, Wendy Leisenring, K. Robin Yabroff, Gregory T. Armstrong, Paul Nathan, Nandita Khera

Blood (2022) 140 (Supplement 1): 10981–10982.

https://doi.org/10.1182/blood-2022-159132

Published: 2022

Journal Articles

Epigenetic Age Acceleration and Neurocognitive Function Among Long-Term Survivors of Pediatric Hodgkin Lymphoma: A Report from the St. Jude Lifetime Cohort

AnnaLynn M Williams, Qian Dong, Nicholas S. Phillips, Matt J. Ehrhardt, Deokumar Srivastava, Sedigheh Mirzaei Salehabadi, Yutaka Yasui, Kirsten K. Ness, Melissa M. Hudson, Leslie L. Robison, Kevin R. Krull, Zhaoming Wang

Blood (2022) 140 (Supplement 1): 2181–2182.

https://doi.org/10.1182/blood-2022-159026

Published: 2022

Journal Articles

Specific Clonal Mutations Are Predictive of Therapy-Related Myeloid Neoplasms (tMN) after Autologous Peripheral Blood Stem Cell Transplantation (aPBSCT) for Lymphoma

Smita Bhatia, Chengcheng Yan, Melissa A Richard, Jianbo He, Alysia Bosworth, David Crossman, Purnima Singh, Lindsey Hageman, Saro H. Armenian, Julie M. Vose, Daniel J. Weisdorf, Yutaka Yasui, Benjamin L. Ebert, Christopher J. Gibson, Stephen J Forman, Ravi Bhatia

Blood (2022) 140 (Supplement 1): 295–297.

https://doi.org/10.1182/blood-2022-165604

Published: 2022

Journal Articles

Modifiable risk factors for neurocognitive and psychosocial problems after Hodgkin lymphoma

AnnaLynn M. Williams, Sedigheh Mirzaei Salehabadi, Mengqi Xing, Nicholas S. Phillips, Matthew J. Ehrhardt, Rebecca Howell, Yutaka Yasui, Kevin C. Oeffinger, Todd Gibson, Eric J. Chow, Wendy Leisenring, Deokumar Srivastava, Melissa M. Hudson, Leslie L. Robison, Gregory T. Armstrong, Kevin R. Krull

Blood (2022) 139 (20): 3073–3086.

https://doi.org/10.1182/blood.2021013167

Published: 2022

Includes: Supplemental data

Journal Articles

The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity

Andrea C. Lo, Amy Liu, Qi Liu, Yutaka Yasui, Sharon M. Castellino, Kara M. Kelly, Alex F. Herrera, Jonathan W. Friedberg, Debra L. Friedman, Cindy L. Schwartz, Samuel Bergeron-Gravel, Hitesh Dama, Kenneth B. Roberts, Louis S. Constine, David Hodgson

Blood (2021) 138 (Supplement 1): 881.

https://doi.org/10.1182/blood-2021-147678

Published: 2021

Journal Articles

Prevalence and Predictors of Neurocognitive Impairment in Long-Term Survivors of Childhood Hodgkin Lymphoma: A Report from the Childhood Cancer Survivor Study

Annalynn M Williams, PhD, Mengqi Xing, MR, Sedigheh Mirzaei Salehabadi, PhD, Yutaka Yasui, PhD, Matt J. Ehrhardt, MD MS, Rebecca M Howell, PhD, Kevin C Oeffinger, MD, Todd Gibson, PhD, Eric Chow, MD, Wendy Leisenring, ScD, Deokumar Srivastava, PhD, Leslie L. Robison, PhD, Gregory T Armstrong, MD, Kevin R. Krull, PhD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-136339

Published: 2020

Journal Articles

Associations between Persistent Inflammation and Oxidative Stress with Neurocognitive Impairment in Long-Term Hodgkin Lymphoma Survivors and Community Controls

AnnaLynn M Williams, PhD, Daniel A. Mulrooney, MDMS, Wei Liu, PhD, Matt J. Ehrhardt, MD MS, Sedigheh Mirzaei Salehabadi, PhD, Angela Panoskaltsis-Mortari, PhD, Deokumar Srivastava, PhD, Yutaka Yasui, PhD, Melissa M. Hudson, MD, Leslie L. Robison, PhD, Noah D Sabin, MD JD, Kevin R. Krull, PhD

Blood (2019) 134 (Supplement_1): 3479.

https://doi.org/10.1182/blood-2019-126041

Published: 2019

Journal Articles

Precision Medicine for Sickle Cell Disease through Whole Genome Sequencing

Blood (2018) 132 (Supplement 1): 3641.

https://doi.org/10.1182/blood-2018-99-117606

Published: 2018

Journal Articles

Estimated Late Health Outcomes in Children Newly Diagnosed with Mature B-Cell Non-Hodgkin Lymphoma Treated with Contemporary LMB Chemotherapy Based upon Similarly Treated Participants in the Childhood Cancer Survivor Study (CCSS)

Matthew J. Ehrhardt, MD MS, Yan Chen, MMath, John Sandlund, MD, Elizabeth C. Bluhm, MD, Robert J. Hayashi, MD, Wendy M. Leisenring, ScD, Monika L. Metzger, MD, Kirsten K. Ness, PhD, Kevin R. Krull, PhD, Kevin C. Oeffinger, MD, Leslie L. Robison, PhD, Yutaka Yasui, PhD, Gregory T. Armstrong, MD MSCE, Melissa M. Hudson, MD, Daniel A. Mulrooney, MD

Blood (2016) 128 (22): 3609.

https://doi.org/10.1182/blood.V128.22.3609.3609

Published: 2016

Journal Articles

Generation of BCR-ABL Reactive CD4+ T Helper Cells By Reprograming and Redifferentiation

Norihiro Ueda, MD, Yasusi Uemura, PhD, Rhong Zhang, MD PhD, Shuichi Kitayama, Yutaka Yasui, Minako Tatsumi, Tian-Yi Liu, MD PhD, Kiyotaka Kuzushima, MD PhD, Hitoshi Kiyoi, MD PhD, Tomoki Naoe, MD PhD, Shin Kaneko, MD PhD

Blood (2015) 126 (23): 3424.

https://doi.org/10.1182/blood.V126.23.3424.3424

Published: 2015

Journal Articles

The VKORC1 and CYP2C9 Genotypes Significantly Affect Vitamin K Antagonist Dosing Only in Patients Aged 20 Years or Older

Ulrike Nowak-Gottl, MD, Kevin Dietrich, Andre Franke, Noha Sharaf El-Din, Yutaka Yasui, Lesley G Mitchell

Blood (2011) 118 (21): 1243.

https://doi.org/10.1182/blood.V118.21.1243.1243

Published: 2011

Journal Articles

In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes

Ulrike Nowak-Göttl, Kevin Dietrich, Daria Schaffranek, Noha Sharaf Eldin, Yutaka Yasui, Christof Geisen, Lesley G. Mitchell

Blood (2010) 116 (26): 6101–6105.

https://doi.org/10.1182/blood-2010-05-283861

Published: 2010

Includes: Supplemental data

Journal Articles

Generation of Monoclonal TCR-Expressing Human T-Lineage Lymphocytes From Induced Pluripotent Stem Cells of Single Peripheral T-Lymphocyte Origin

Toshinobu Nishimura, Shin Kaneko, M.D., Ph.D., Haruo Gotoh, Naoya Takayama, M.D., Ph.D., Takafumi Shimizu, Shoichi Iriguchi, Yoko Tajima, Yutaka Yasui, Nobukazu Watanabe, M.D., Ph.D., Satoshi Takahashi, M.D., Ph.D., Koji Eto, M.D., Ph.D., Hiromitsu Nakauchi, M.D., Ph.D.

Blood (2010) 116 (21): 490.

https://doi.org/10.1182/blood.V116.21.490.490

Published: 2010

Journal Articles

Twenty-five–year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study

Rajen Mody, Suwen Li, Douglas C. Dover, Stephen Sallan, Wendy Leisenring, Kevin C. Oeffinger, Yutaka Yasui, Leslie L. Robison, Joseph P. Neglia

Blood (2008) 111 (12): 5515–5523.

https://doi.org/10.1182/blood-2007-10-117150

Published: 2008

Includes: Supplemental data

Journal Articles

Twenty Years of Follow-Up among Survivors of Childhood and Young Adult Acute Myeloid Leukemia (AML): A Report from the Childhood Cancer Survivor Study (CCSS).

Daniel A. Mulrooney, MD, Douglas C. Dover, MSc., Yutaka Yasui, Ph.D., Kirsten K. Ness, Ph.D., Ann C. Mertens, Ph.D., Joseph P. Neglia, M.D., Charles A. Sklar, M.D., Leslie L. Robison, Ph.D., Stella M. Davies, M.D./Ph.D.

Blood (2006) 108 (11): 560.

https://doi.org/10.1182/blood.V108.11.560.560

Published: 2006

Journal Articles

Twenty Year Follow up of Survivors of Childhood Acute Lymphoid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS).

Rajen Mody, MD, Douglas Dover, M.Sc., Yutaka Yasui, Ph.D., Stephen Sallan, MD, Leslie Robison, Ph.D., Joseph Neglia, MD

Blood (2006) 108 (11): 1823.

https://doi.org/10.1182/blood.V108.11.1823.1823

Published: 2006

NARROW

Incidence and Prognosis of Primary Malignancies in Ataxia-Telangiectasia Patients: A Report from the Ataxia-Telangiectasia Clinical Center (ATCC)

Improved Neurocognitive Outcomes with Contemporary Treatments in Survivors of Early Adolescent and Young Adult Hematologic Malignancies from the Childhood Cancer Survivor Study

New Onset Neurocognitive Impairment in Long-Term Survivors of Early Adolescent and Young Adult Hematologic Malignancies: A Report from the Childhood Cancer Survivor Study

Development of a Genetic Risk Score for Albuminuria in Pediatric Patients with Sickle Cell Anemia

A Comparison of Financial Hardship Among Survivors of Childhood Cancer Treated with and without Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study

Epigenetic Age Acceleration and Neurocognitive Function Among Long-Term Survivors of Pediatric Hodgkin Lymphoma: A Report from the St. Jude Lifetime Cohort

Specific Clonal Mutations Are Predictive of Therapy-Related Myeloid Neoplasms (tMN) after Autologous Peripheral Blood Stem Cell Transplantation (aPBSCT) for Lymphoma

Modifiable risk factors for neurocognitive and psychosocial problems after Hodgkin lymphoma

The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity

Prevalence and Predictors of Neurocognitive Impairment in Long-Term Survivors of Childhood Hodgkin Lymphoma: A Report from the Childhood Cancer Survivor Study

Associations between Persistent Inflammation and Oxidative Stress with Neurocognitive Impairment in Long-Term Hodgkin Lymphoma Survivors and Community Controls

Precision Medicine for Sickle Cell Disease through Whole Genome Sequencing

Estimated Late Health Outcomes in Children Newly Diagnosed with Mature B-Cell Non-Hodgkin Lymphoma Treated with Contemporary LMB Chemotherapy Based upon Similarly Treated Participants in the Childhood Cancer Survivor Study (CCSS)

Generation of BCR-ABL Reactive CD4+ T Helper Cells By Reprograming and Redifferentiation

The VKORC1 and CYP2C9 Genotypes Significantly Affect Vitamin K Antagonist Dosing Only in Patients Aged 20 Years or Older

In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes

Generation of Monoclonal TCR-Expressing Human T-Lineage Lymphocytes From Induced Pluripotent Stem Cells of Single Peripheral T-Lymphocyte Origin

Twenty-five–year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study

Twenty Years of Follow-Up among Survivors of Childhood and Young Adult Acute Myeloid Leukemia (AML): A Report from the Childhood Cancer Survivor Study (CCSS).

Twenty Year Follow up of Survivors of Childhood Acute Lymphoid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only